Clinical Trials Logo

Immunity clinical trials

View clinical trials related to Immunity.

Filter by:

NCT ID: NCT03923894 Completed - Immunity Clinical Trials

the Efficacy and Safety of Blueberry Yeast Fermentation Freeze Dying Powder on Promotion of Immunity

Start date: February 14, 2019
Phase: N/A
Study type: Interventional

This study was conducted to investigated the effects of daily supplementation of Blueberry Yeast Fermentation Freeze Dying Powder on Promotion of Immunity.

NCT ID: NCT03336086 Completed - Weight Loss Clinical Trials

Effect of Weight Reduction on Immunity

Start date: March 20, 2012
Phase: Phase 3
Study type: Interventional

This study included two groups of premenopausal healthy obese women. Experimental group underwent a weight loss program involved a low calorie diet plus anti-obesity drugs and moderate physical activity and control group underwent an ad libitum diet. At baseline and after a 10-15% weight loss lymphocyte subgroups were analyzed and compared between two group.

NCT ID: NCT03067714 Completed - Immunity Clinical Trials

A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on Gut Microbiota Composition and Clinical Effectiveness in Infants at High Risk of Developing Allergy

TEMPO
Start date: March 30, 2017
Phase: Phase 3
Study type: Interventional

With the rising prevalence of allergic diseases and the subsequent risk of developing other immune-related disorders, primary prevention of allergy has become a major priority. It is generally acknowledged that breastfeeding is one of the main pillars in allergy prevention. Infant formulas based on hydrolysed proteins have been developed to be used by infants at increased risk of developing allergy in case a mother is unable or chooses not to breastfeed her infant. It has recently been demonstrated that the gut microbiota composition and microbiota activity of infants receiving an infant formula based on partially hydrolysed proteins, supplemented with oligosaccharides, is more similar to breastfed infants than to infants receiving standard cow's milk formula, demonstrated by increased levels of bifidobacteria. However the interaction between microbial changes impacted by an hypoallergenic concept and its influence on early life immune development should be further explored. The aim of the present study is therefore to investigate the bifidogenic effect of a hypoallergenic formula supplemented with prebiotics and probiotics compared to standard infant formula in infants at increased risk of developing allergic disease. This study will secondary assess the effects of this concept on the development of allergic manifestations up to the age of 12 months, which will be verified in a separate clinical study MAESTRO as primary outcome. Furthermore, the effects on growth and safety will be studied.

NCT ID: NCT02814617 Completed - Immunity Clinical Trials

The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity

Start date: September 2015
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators performed randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Cordyceps sinensis mycelium culture extract (Paecilomyces hepiali, CBG-CS-2) on promotion of immunity. The investigators measured promotion of immunity parameters , including Cytotoxicity, Cytokine (IL-1β, IL-2, IL-4, IL-10, IL-12, IFN-γ, TNF-α).

NCT ID: NCT02244372 Completed - Immunity Clinical Trials

Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity

Start date: September 2014
Phase: N/A
Study type: Interventional

The investigators performed randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Cordyceps sinensis mycelium culture extract (Paecilomyces hepiali, CBG-CS-2) on promotion of immunity. The investigators measured promotion of immunity parameters , including Cytotoxicity, Cytokine (IL-4, IL-6, IL-12, IFN-γ, TNF-α), hs-CRP, antibody titer, and upper respiratory tract infection(URI)

NCT ID: NCT01885728 Completed - Immunity Clinical Trials

Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical Patients

Start date: July 2013
Phase: N/A
Study type: Interventional

The primary objective of this study is to characterize the immune-modulatory effects of arginine-rich nutritional supplements in patients undergoing surgery. Numerical and functional changes of all circulating immune cells will be assessed with mass cytometry.

NCT ID: NCT01736787 Completed - Immunity Clinical Trials

Efficacy and Safety of Cauliflower Mushroom Extract on Promotion of Immunity

Start date: September 17, 2012
Phase: N/A
Study type: Interventional

The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Cauliflower Mushroom extract on promotion of immunity. The investigators measured promotion of immunity parameters , including Cytotoxicity, Cytokine (IL-4, IL-10, IFN- γ, TNF-α), and CBC (WBC, RBC, Hb, Hct, MCV, MCH, MCHC, PLT), and monitored their blood pressure.

NCT ID: NCT01657656 Completed - Tuberculosis Clinical Trials

Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia

Start date: October 2012
Phase: N/A
Study type: Interventional

Hypothesis That improving vitamin D status among TB patients will speed the pace of bacteriological cure, and will enhance immune responses to TB infection

NCT ID: NCT01109914 Completed - Clinical trials for Kidney Transplantation

Mucosal Response in Immunocompromised Host

MICH
Start date: April 2010
Phase: Phase 4
Study type: Interventional

The aim of this study is to verify whether vaccination with Dukoral® (SBL Vaccines) induces an immune response in renal transplant recipients on prednisolone in combination with either a calcineurin inhibitor CNI) or mycophenolate mofetil (MMF).

NCT ID: NCT00990002 Completed - Immunity Clinical Trials

Investigation of A Children's Beverage Containing Different Probiotics

Start date: September 2009
Phase: N/A
Study type: Observational

Investigating different bioactive ingredients in children's beverages and the effect on blood serum markers.